About Porosome Therapeutics
Porosome Therapeutics is a private company based in Boston, Massachusetts, incorporated in 2021 in Delaware. It has reported $3,930,000 raised in two offerings on Form D since June 2022. Its chief executive is Guillermo Marmol.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 8, 2023 | Sep 14, 2023amended Mar 24, 2026 | $3,625,000target not set | 7 | $517K | EquityRule 506(b) | Form D/A ↗3 earlier filings |
| Jun 7, 2022 | Jun 24, 2022 | $305,000target not set | 3 | $101K | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $3,930,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Porosome Therapeutics's Form D filed Mar 24, 2026.
GM
Guillermo Marmol
Co-Founder & Chief Executive Officer
Sources
- SECPorosome Therapeutics, Inc. Form D/A, filed Jun 3, 2025
- SECPorosome Therapeutics, Inc. Form D/A, filed Jul 25, 2024
- SECPorosome Therapeutics, Inc. Form D, filed Sep 14, 2023
- SECPorosome Therapeutics, Inc. filing history
- CompanyContact
- CompanyTeam
- PressPorosome Therapeutics drug development partnership announcement